A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant

PHASE3CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Hepatitis B
Interventions
DRUG

Zutectra

Subcutaneous injections of Zutectra up to 1,000 IU (2 ml) per week.

Trial Locations (16)

10126

Molinette Hospital, Torino

20162

Azienda Ospedaliera Ospedale Niguarda Ca Granda-Chirurgia, Milan

28007

Hospital General Universitario Gregorio Maranon, Madrid

28041

Hospital 12 de Octubre, Madrid

35122

Azienda Ospedialera Universitaria di Padova, Padua

40138

S. Orsola Hospital, Bologna

41100

Liver and Multivisceral Transplant Center, University of Modena and Reggio Emilia, Modena

54124

Azienda Ospedaliero-Universitaria Pisana, Pisa

69004

Hopital de la Croix Rousse, Lyon

70124

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Bari

94804

Hôpital Paul Brousse, Villejuif

CA 09135

"Azienda ospedaliera G. Brutzu di Cagliari", Cagliari

00133

Fondazione Policlinico Tor-Vergata U.O.C., Roma

08036

Hospital Clinic de Barcelona, Barcelona

B15 2TH

University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham

SE5 9RS

King's College Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

AMS Advanced Medical Services GmbH

INDUSTRY

lead

Biotest

INDUSTRY

NCT01856413 - A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant | Biotech Hunter | Biotech Hunter